申请人:Indiana University Research and Technology Corporation
公开号:US10947224B2
公开(公告)日:2021-03-16
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.